Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANKRD50 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SERPINA12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SSH1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | MYO18B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF224 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | POF1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | STARD10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | RITA1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | CCNG1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BCAS4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |